Vir Biotechnology
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $238,946 | $-29 | $64,070 | $240 |
Gross Profit | 238,946 | -2,840 | 430,631 | -151,212 |
EBITDA | 78,443 | -122,714 | -40,162 | -159,975 |
EBIT | 75,641 | -125,525 | -43,060 | -162,973 |
Net Income | 80,080 | -125,695 | -42,923 | -163,141 |
Net Change In Cash | 238,946 | -29 | 64,070 | 240 |
Free Cash Flow | -9,482 | -132,776 | -21,392 | -167,887 |
Cash | 278,729 | 276,086 | 234,107 | 170,084 |
Basic Shares | 168,879 | 147,356 | 139,232 | 138,930 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $68,556 | $74,205 | $86,180 | $1,615,797 |
Gross Profit | 56,850 | -404,440 | -486,647 | 994,830 |
EBITDA | -426,090 | -508,912 | -641,637 | 761,063 |
EBIT | -437,770 | -523,471 | -661,088 | 754,280 |
Net Income | -437,987 | -521,960 | -615,061 | 515,837 |
Net Change In Cash | 68,556 | 74,205 | 86,180 | 1,615,797 |
Free Cash Flow | -396,613 | -453,653 | -800,358 | 1,595,247 |
Cash | 234,107 | 222,947 | 241,576 | 848,631 |
Basic Shares | 138,520 | 136,247 | 134,130 | 134,810 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.47 |
2026-03-31 | -$0.85 |
2025-12-31 | -$0.31 |
2025-09-30 | -$1.17 |